The Effectiveness of Inodilators in Reducing Short Term Mortality among Patient with Severe Cardiogenic Shock: A Propensity-Based Analysis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Pirracchio, Romain ^a   Parenica, Jiri ^c   Resche Rigon, Matthieu ^b   Chevret, Sylvie ^b   Spinar, Jindrich ^c   Jarkovsky, Jiri ^c   Zannad, Faiez ^e   Alla, François ^e   Mebazaa, Alexandre ^d  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^d HÔPITAL LARIBOISIÈRE   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CARDIOVASCULAR AGENT; DOBUTAMINE; DOPAMINE; HYPERTENSIVE FACTOR; INODILATOR; INOPRESSOR; LEVOSIMENDAN; NORADRENALIN; PHOSPHODIESTERASE III INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PROBABILITY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; SHORT TERM MORTALITY;

AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPENSITY SCORE; SHOCK, CARDIOGENIC; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84881568865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071659     Document Type: Article

References (31)

1. Krenn L, Delle Karth G, (2011) Essential lessons in cardiogenic shock: epinephrine versus norepinephrine/dobutamine. Crit Care Med 39: 583-584 doi:10.1097/CCM.0b013e318208e381.
2. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, et al. (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33: 1787-1847 doi:10.1093/eurheartj/ehs104.
3. Krejci V, Hiltebrand LB, Sigurdsson GH, (2006) Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med 34: 1456-1463 doi:10.1097/01.CCM.0000215834.48023.57.
4. Thompson RB, van den Bos EJ, Esposito DJ, Owen CH, Glower DD, (2003) The effects of acute afterload change on systolic ventricular function in conscious dogs with normal vs. failing hearts. Eur J Heart Fail 5: 741-749.
5. Capomolla S, Pozzoli M, Opasich C, Febo O, Riccardi G, et al. (1997) Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. Am Heart J 134: 1089-1098.
6. Hochman JS, (2003) Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107: 2998-3002 doi:10.1161/01.CIR.0000075927.67673.F2.
7. Zannad F, Mebazaa A, Juillière Y, Cohen-Solal A, Guize L, et al. (2006) Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 8: 697-705 doi:10.1016/j.ejheart.2006.01.001.
8. Mebazaa A, Parissis J, Porcher R, Gayat E, Nikolaou M, et al. (2011) Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Med 37: 290-301 doi:10.1007/s00134-010-2073-4.
9. How O-J, Røsner A, Kildal AB, Stenberg TA, Gjessing PF, et al. (2010) Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock. Transl Res J Lab Clin Med 156: 273-281 doi:10.1016/j.trsl.2010.07.011.
10. Levy B, Perez P, Perny J, Thivilier C, Gerard A, (2011) Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med 39: 450-455 doi:10.1097/CCM.0b013e3181ffe0eb.
11. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Plos Med 4: e296 doi:10.1371/journal.pmed.0040296.
12. Spinar J, Parenica J, Vitovec J, Widimsky P, Linhart A, et al. (2011) Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care Lond Engl 15: R291 doi:10.1186/cc10584.
13. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, et al. (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26: 384-416 doi:10.1093/eurheartj/ehi044.
14. Paul R Rosenbaum, Rubin DB, (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41-55.
15. Hernán MA, Brumback B, Robins JM, (2000) Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiol Camb Mass 11: 561-570.
16. Austin PC, (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28: 3083-3107 doi:10.1002/sim.3697.
17. White IR, Kalaitzaki E, Thompson SG, (2011) Allowing for missing outcome data and incomplete uptake of randomised interventions, with application to an Internet-based alcohol trial. Stat Med 30: 3192-3207 doi:10.1002/sim.4360.
18. White IR, Royston P, (2009) Imputing missing covariate values for the Cox model. Stat Med 28: 1982-1998 doi:10.1002/sim.3618.
19. Rubin DB, (1996) Multiple Imputation After 18+ Years. J Am Stat Assoc 91: 473-489.
20. Heusch G, (1990) Alpha-adrenergic mechanisms in myocardial ischemia. Circulation 81: 1-13.
21. Nikolaidis LA, Hentosz T, Doverspike A, Huerbin R, Stolarski C, et al. (2002) Catecholamine stimulation is associated with impaired myocardial O(2) utilization in heart failure. Cardiovasc Res 53: 392-404.
22. Reynolds HR, Hochman JS, (2008) Cardiogenic shock: current concepts and improving outcomes. Circulation 117: 686-697 doi:10.1161/CIRCULATIONAHA.106.613596.
23. Palizas F, Dubin A, Regueira T, Bruhn A, Knobel E, et al. (2009) Gastric tonometry versus cardiac index as resuscitation goals in septic shock: a multicenter, randomized, controlled trial. Crit Care Lond Engl 13: R44 doi:10.1186/cc7767.
24. Boerma EC, Koopmans M, Konijn A, Kaiferova K, Bakker AJ, et al. (2010) Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial. Crit Care Med 38: 93-100 doi:10.1097/CCM.0b013e3181b02fc1.
25. Jung C, Rödiger C, Fritzenwanger M, Schumm J, Lauten A, et al. (2009) Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock. Clin Res Cardiol Off J Ger Card Soc 98: 469-475 doi:10.1007/s00392-009-0018-0.
26. De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL, (2004) Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 147: 91-99.
27. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, et al. (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362: 779-789 doi:10.1056/NEJMoa0907118.
28. Den Uil CA, Lagrand WK, Spronk PE, van der Ent M, Jewbali LSD, et al. (2009) Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure. Eur J Heart Fail 11: 386-390 doi:10.1093/eurjhf/hfp021.
29. Bayram M, De Luca L, Massie MB, Gheorghiade M, (2005) Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 96: 47G-58G doi:10.1016/j.amjcard.2005.07.021.
30. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, et al. (2002) Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. Jama J Am Med Assoc 287: 1541-1547.
31. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, et al. (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149: 209-216 doi:10.1016/j.ahj.2004.08.005.